Suppr超能文献

舌根部鳞状细胞癌的根治性放疗

Definitive radiotherapy for squamous cell carcinoma of the base of tongue.

作者信息

Mendenhall William M, Morris Christopher G, Amdur Robert J, Hinerman Russell W, Werning John W, Villaret Douglas B

机构信息

Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL 32610-0385, USA.

出版信息

Am J Clin Oncol. 2006 Feb;29(1):32-9. doi: 10.1097/01.coc.0000189680.60262.eb.

Abstract

OBJECTIVE

To evaluate definitive radiotherapy (RT) for treatment of base of tongue cancer.

METHODS

There were 333 patients with squamous cell carcinoma of the base of tongue treated with definitive RT and had follow-up from 0.2 to 26.2 years. Follow-up on living patients ranged from 1.2 to 26.2 years (median, 6.6 years).

RESULTS

Local control rates at 5 years were: T1, 98%; T2, 92%; T3, 82%; and T4, 53%. The 5-year rates of local-regional control rates were: I-II, 100%; III, 82%; IVA, 87%; and IVB, 58%. The rates of absolute and cause-specific survival at 5 years were as follows: I-II, 67% and 91%; III, 66% and 77%; IVA, 67% and 84%; and IVB, 33% and 45%. Severe complications developed in 52 patients (16%).

CONCLUSION

Our data and review of the pertinent literature reveal that the local-regional control rates and survival rates after RT were comparable to those after surgery, and the morbidity associated with RT was less.

摘要

目的

评估根治性放疗(RT)治疗舌根癌的效果。

方法

333例舌根鳞状细胞癌患者接受了根治性放疗,并进行了0.2至26.2年的随访。存活患者的随访时间为1.2至26.2年(中位数为6.6年)。

结果

5年局部控制率分别为:T1期98%;T2期92%;T3期82%;T4期53%。5年局部区域控制率分别为:I-II期100%;III期82%;IVA期87%;IVB期58%。5年绝对生存率和病因特异性生存率如下:I-II期分别为67%和91%;III期分别为66%和77%;IVA期分别为67%和84%;IVB期分别为33%和45%。52例患者(16%)出现严重并发症。

结论

我们的数据及相关文献回顾显示,放疗后的局部区域控制率和生存率与手术相当,且放疗相关的发病率较低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验